Second-generation antihistamines: actions and efficacy in the management of allergic disorders
- PMID: 15669879
- DOI: 10.2165/00003495-200565030-00004
Second-generation antihistamines: actions and efficacy in the management of allergic disorders
Abstract
Antihistamines are useful medications for the treatment of a variety of allergic disorders. Second-generation antihistamines avidly and selectively bind to peripheral histamine H1 receptors and, consequently, provide gratifying relief of histamine-mediated symptoms in a majority of atopic patients. This tight receptor specificity additionally leads to few effects on other neuronal or hormonal systems, with the result that adverse effects associated with these medications, with the exception of noticeable sedation in about 10% of cetirizine-treated patients, resemble those of placebo overall. Similarly, serious adverse drug reactions and interactions are uncommon with these medicines. Therapeutic interchange to one of the available second-generation antihistamines is a reasonable approach to limiting an institutional formulary, and adoption of such a policy has proven capable of creating substantial cost savings. Differences in overall efficacy and safety between available second-generation antihistamines, when administered in equivalent dosages, are not large. However, among the antihistamines presently available, fexofenadine may offer the best overall balance of effectiveness and safety, and this agent is an appropriate selection for initial or switch therapy for most patients with mild or moderate allergic symptoms. Cetirizine is the most potent antihistamine available and has been subjected to more clinical study than any other. This agent is appropriate for patients proven unresponsive to other antihistamines and for those with the most severe symptoms who might benefit from antihistamine treatment of the highest potency that can be dose-titrated up to maximal intensity.
Similar articles
-
H1-antihistamines in the elderly.Clin Allergy Immunol. 2002;17:465-81. Clin Allergy Immunol. 2002. PMID: 12113227 Review.
-
Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists.Otolaryngol Head Neck Surg. 1993 Sep;109(3 Pt 2):584-92. Otolaryngol Head Neck Surg. 1993. PMID: 8105440
-
Ebastine in allergic rhinitis and chronic idiopathic urticaria.Allergy. 2008 Dec;63 Suppl 89:1-20. doi: 10.1111/j.1398-9995.2008.01897.x. Allergy. 2008. PMID: 19032340 Review.
-
Do antihistamines have a role in asthma therapy?Pharmacotherapy. 2001 Mar;21(3 Pt 2):28S-33S. doi: 10.1592/phco.21.4.28s.34264. Pharmacotherapy. 2001. PMID: 11253865 Review.
-
Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective study.Clin Drug Investig. 2010;30(1):15-34. doi: 10.2165/11530910-000000000-00000. Clin Drug Investig. 2010. PMID: 19995095
Cited by
-
Determination of Some Non-sedating Antihistamines via Their Native Fluorescence and Derivation of Some Quantitative Fluorescence Intensity - Structure Relationships.J Fluoresc. 2015 Nov;25(6):1695-709. doi: 10.1007/s10895-015-1656-4. Epub 2015 Oct 6. J Fluoresc. 2015. PMID: 26439930
-
Selecting the optimal oral antihistamine for patients with allergic rhinitis.Drugs. 2006;66(18):2309-19. doi: 10.2165/00003495-200666180-00004. Drugs. 2006. PMID: 17181374 Review.
-
Flight safety risk assessment of self-medication among fighter pilots: a cross-sectional study.Int J Clin Pharm. 2023 Dec;45(6):1415-1423. doi: 10.1007/s11096-023-01611-y. Epub 2023 Jul 10. Int J Clin Pharm. 2023. PMID: 37430120
-
Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial.Trials. 2016 Jun 30;17(1):305. doi: 10.1186/s13063-016-1432-z. Trials. 2016. PMID: 27363578 Free PMC article. Clinical Trial.
-
H1 antihistamines: current status and future directions.World Allergy Organ J. 2008 Sep;1(9):145-55. doi: 10.1186/1939-4551-1-9-145. World Allergy Organ J. 2008. PMID: 23282578 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical